Back

Patients in New York Heart Association functional class I might benefit from primary prevention implantable cardioverter defibrillator therapy

18 March 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Ventricular arrhythmias and sudden cardiac death (clinical aspects) Device Treatment of Ventricular Arrhythmias and SCD EHRA Premium Access EHRA 2018

About the speaker

Photo
Miss Anne-Lotte van der Lingen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
First degree atrioventricular block on basal electrocardiogram predicts future arrhythmic events in patients with brugada syndrome
Doctor M. Testolina (Padova, IT)
Abstract
Presentation thumbnail
It is not only about the looks: safety and feasibility of inter-muscular generator placement of the subcutaneous implantable cardioverter-defibrillator.
Doctor J. Kuschyk (Mannheim, DE)
Presentation thumbnail
Prognosis of Patients with Vasospastic Angina Resuscitated from Cardiac Arrest
Doctor A. Isshiki (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Patients managed by non-cardiologists are less likely to be assessed for implantable cardioverter defibrillators
Doctor A. Mistry (Nottingham, GB)
Abstract Slides
Presentation thumbnail
Prospective non-invasive evaluation of a novel ECG-based restitution biomarker for prediction of sudden cardiac death risk in ischaemic cardiomyopathy
Doctor S. Siddiqui (Warwick, GB)
Abstract

Access the full session

Session thumbnail
Ventricular arrhythmias and sudden cardiac death (clinical aspects)

The Event

Event poster

EHRA 2018

18 March 2018 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources